Orient EuroPharma Co., Ltd. (TPEX:4120)

Market Cap	4.11B -5.9%
Revenue (ttm)	4.60B +4.6%
Net Income	-567.39M
EPS	-6.54
Shares Out	86.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	4.00 (8.45%)
Ex-Dividend Date	n/a

Volume	11,119
Average Volume	31,005
Open	47.80
Previous Close	47.50
Day's Range	47.10 - 47.80
52-Week Range	42.60 - 58.90
Beta	0.14
RSI	57.27
Earnings Date	May 12, 2026

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include weight management, andrology, cardiovascular, respiratory, neurology, cardiovascular, metabolism, obstetrics and gynecology, antibiotic, immunology, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplements for liquid nutrition, regular blood lipids, L-arginines, agile movements, and improved sleep qualities under the N...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 339
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4120

Financial Performance

In 2025, Orient EuroPharma's revenue was 4.60 billion, an increase of 4.64% compared to the previous year's 4.39 billion. Losses were -567.39 million, 99.8% more than in 2024.